Journal List > Korean J Healthc Assoc Infect Control Prev > v.24(2) > 1140850

Song: Diagnosis and Treatment of Latent Tuberculosis Infection for Healthcare Workers

Figures and Tables

Table 1

Treatment recommendations for latent tuberculosis


*Diabetic patients are excluded from latent TB diagnostic testing reimbursement targets.

Abbreviations: HIV, human immunodeficiency virus; TST, tuberculin skin test; IGRA, interferon-gamma releasing assay.

Table 2

Classification of healthcare workers based on the risk for exposure to tuberculosis*


*Classification based on Korea Centers for Disease Control and Prevention (KCDC).


1. Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015; 46:1563–1576.
2. Kim HA, Shin JY, Kim HR, Lee JE, Kim JH, Kong IS. Review on global burden of tuberculosis, 2017. Public Health Weekly Report. 2019; 12:208–214.
3. Cho KS. Tuberculosis control in the Republic of Korea. Health Soc Welf Rev. 2017; 37:179–212.
4. Joint Committee for the Revision of Korean Guidelines for Tuberculosis. Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. Cheongju: Korea Centers for Disease Control and Prevention;2017. p. 1–232.
5. Choi CM, Kang CI, Kim DH, Kim CH, Kim HJ, Lee CH, et al. The role of TST in the diagnosis of latent tuberculosis infection among military personnel in South Korea. Int J Tuberc Lung Dis. 2006; 10:1342–1346.
6. Lee SW, Oh SY, Lee JB, Choi CM, Kim HJ. Tuberculin skin test distribution following a change in BCG vaccination policy. PLoS One. 2014; 9:e86419.
7. Mok JH. Diagnosis and treatment of latent tuberculosis infection in healthcare workers. Tuberc Respir Dis (Seoul). 2016; 79:127–133.
8. Yeon JH, Seong H, Hur H, Park Y, Kim YA, Park YS, et al. Prevalence and risk factors of latent tuberculosis among Korean healthcare workers using whole-blood interferon-γ release assay. Sci Rep. 2018; 8:10113.
9. Kim S, Choi H, Jang YJ, Park SH, Lee H. Prevalence of and factors related to latent tuberculous infection among all employees in a referral hospital. Int J Tuberc Lung Dis. 2018; 22:1329–1335.
10. Lee EH, Kim SJ, Ha EJ, Park ES, Choi JY, Leem AY, et al. Treatment of latent tuberculous infection among health care workers at a tertiary hospital in Korea. Int J Tuberc Lung Dis. 2018; 22:1336–1343.
11. Lee SH, Choi YH. Prevalence and risk factors of latent tuberculosis infection among healthcare workers [MD dissertation]. Suwon: Ajou University;2019.
12. Park Y, Kim SY, Kim JW, Park MS, Kim YS, Chang J, et al. Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis. PLoS One. 2018; 13:e0204035.
13. Lee H, Koo GW, Min JH, Park TS, Park DW, Moon JY, et al. Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay. Sci Rep. 2019; 9:61.
14. Swift MD, Molella RG, Vaughn AIS, Breeher LE, Newcomb RD, Abdellatif S, et al. Determinants of latent tuberculosis treatment acceptance and completion in healthcare personnel. Clin Infect Dis. in press 2019.

Joon Young Song

Similar articles